[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Chalan et al., 2015 - Google Patents

Rheumatoid arthritis, immunosenescence and the hallmarks of aging

Chalan et al., 2015

View HTML
Document ID
15588280662819303590
Author
Chalan P
van den Berg A
Kroesen B
Brouwer L
Boots A
Publication year
Publication venue
Current Aging Science

External Links

Snippet

Age is the most important risk factor for the development of infectious diseases, cancer and chronic inflammatory diseases including rheumatoid arthritis (RA). The very act of living causes damage to cells. A network of molecular, cellular and physiological maintenance …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Chalan et al. Rheumatoid arthritis, immunosenescence and the hallmarks of aging
Trowbridge et al. Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS
Syrett et al. Loss of Xist RNA from the inactive X during B cell development is restored in a dynamic YY1-dependent two-step process in activated B cells
Webb et al. Protein arginine methyltransferase 5 promotes cholesterol biosynthesis–mediated Th17 responses and autoimmunity
Sánchez-Abarca et al. Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting
Yang et al. Critical roles of mTOR Complex 1 and 2 for T follicular helper cell differentiation and germinal center responses
Torres et al. Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity
Coquery et al. BAFF regulates follicular helper T cells and affects their accumulation and interferon‐γ production in autoimmunity
US20220016166A1 (en) T-cell expressing chimeric receptor
JP2019518460A (en) Manipulated Treg cells
JP2020524149A (en) Regulatory T cells, regulatory B cells, and method of regulating immune response using modulator of APRIL-TACI interaction
CN110753755A (en) T cell depletion state specific gene expression regulator and use thereof
Shi et al. TSC1/mTOR-controlled metabolic–epigenetic cross talk underpins DC control of CD8+ T-cell homeostasis
Lee et al. IFNγ signaling endows DCs with the capacity to control type I inflammation during parasitic infection through promoting T-bet+ regulatory T cells
Raugh et al. Nature vs. nurture: FOXP3, genetics, and tissue environment shape Treg function
Zhdanov et al. Contact-independent suppressive activity of regulatory T cells is associated with telomerase inhibition, telomere shortening and target lymphocyte apoptosis
JP2016529208A (en) KIR3DL2 is a useful biomarker and therapeutic target to prevent and treat a subset of cutaneous and non-cutaneous peripheral T-cell lymphomas, respectively
Fraszczak et al. The transcription factors GFI1 and GFI1B as modulators of the innate and acquired immune response
Lucca et al. Co‐inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma
EP3090751A1 (en) Molecular profiling of cd8 t-cells in autochthonous melanoma identifies maf as driver of exhaustion
Crispín et al. T cells
US20140288149A1 (en) Mir-142 and antagonists thereof for treating disease
US12109266B2 (en) Modulating gabarap to modulate immunogenic cell death
Brouwer et al. Rheumatoid arthritis, immunosenescence and the hallmarks of aging
Kuksin Elucidating Cellular Signaling Pathways that Contribute to the Immunopathogenesis of Aplastic Anemia